4//SEC Filing
Atkinson Edward Morrow III 4
Accession 0000875320-25-000236
CIK 0000875320other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:06 PM ET
Size
4.8 KB
Accession
0000875320-25-000236
Insider Transaction Report
Form 4
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
- Sale
Common Stock
2025-11-17$434.58/sh−2,500$1,086,450→ 16,852 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001914164
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:06 PM ET
- Size
- 4.8 KB